Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil H Vaidya

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Alcoholism, Clinical and Experimental Research|May 6, 2009
Carisbamate, a novel antiepileptic candidate compound, attenuates alcohol intake in alcohol-preferring ratsAmir H Rezvani, David H Overstreet, Anil H Vaidya, et al.
Alcoholism, Clinical and Experimental Research|January 9, 2007
Effects of atypical anxiolytic N-phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (JNJ-5234801) on alcohol intake in alcohol-preferring P ratsAmir H Rezvani, David H Overstreet, Edward D Levin, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Potential anxiolytic agents. Part 4: novel orally-active N(5)-substituted pyrido[1,2-a]benzimidazoles with high GABA-A receptor affinityAlfonzo D Jordan, Anil H Vaidya, Daniel I Rosenthal, et al.
Bioorganic & Medicinal Chemistry Letters|April 4, 2006
Diarylacetylene piperidinyl amides as novel anxiolyticsCheryl P Kordik, Chi Luo, Maryann Gutherman, et al.
Bioorganic & Medicinal Chemistry|December 10, 2002
2,3-Diaryl-5-anilino[1,2,4]thiadiazoles as melanocortin MC4 receptor agonists and their effects on feeding behavior in ratsKevin Pan, Malcolm K Scott, Daniel H S Lee, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2015
A selective small molecule NOP (ORL-1 receptor) partial agonist for the treatment of anxietyTina Morgan Ross, Kathleen Battista, Gilles C Bignan, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2002
5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolyticBarry Dubinsky, Anil H Vaidya, Daniel I Rosenthal, et al.
Journal of Biomolecular Screening|July 12, 2003
Virus-based expression systems facilitate rapid target in vivo functionality validation and high-throughput screeningAndrew L Darrow, Kelly A Conway, Anil H Vaidya, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Alcoholism, Clinical and Experimental Research|May 6, 2009
Carisbamate, a novel antiepileptic candidate compound, attenuates alcohol intake in alcohol-preferring ratsAmir H Rezvani, David H Overstreet, Anil H Vaidya, et al.
Alcoholism, Clinical and Experimental Research|January 9, 2007
Effects of atypical anxiolytic N-phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (JNJ-5234801) on alcohol intake in alcohol-preferring P ratsAmir H Rezvani, David H Overstreet, Edward D Levin, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Potential anxiolytic agents. Part 4: novel orally-active N(5)-substituted pyrido[1,2-a]benzimidazoles with high GABA-A receptor affinityAlfonzo D Jordan, Anil H Vaidya, Daniel I Rosenthal, et al.
Bioorganic & Medicinal Chemistry Letters|April 4, 2006
Diarylacetylene piperidinyl amides as novel anxiolyticsCheryl P Kordik, Chi Luo, Maryann Gutherman, et al.
Bioorganic & Medicinal Chemistry|December 10, 2002
2,3-Diaryl-5-anilino[1,2,4]thiadiazoles as melanocortin MC4 receptor agonists and their effects on feeding behavior in ratsKevin Pan, Malcolm K Scott, Daniel H S Lee, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2015
A selective small molecule NOP (ORL-1 receptor) partial agonist for the treatment of anxietyTina Morgan Ross, Kathleen Battista, Gilles C Bignan, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2002
5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolyticBarry Dubinsky, Anil H Vaidya, Daniel I Rosenthal, et al.
Journal of Biomolecular Screening|July 12, 2003
Virus-based expression systems facilitate rapid target in vivo functionality validation and high-throughput screeningAndrew L Darrow, Kelly A Conway, Anil H Vaidya, et al.
Pageof 1